Amidst the coronavirus pandemic, adoption of digital tools has accelerated with use cases expanding across the health care industry (including health systems, payers and biopharma and devices companies). FDA approvals for digital therapeutics and the $38 billion Teladoc-Livongo merger represent significant milestones in the maturation of the digital health sector. This webinar will examine emerging business models and the state of digital health in a very dynamic clinical, reimbursement and regulatory environment.

Register Here

Hosted by Harvard Medical School Office for External Education.

Featured Speaker

Bill Evans, CEO & Managing Director of Rock Health

Bill is a father and husband who works in healthcare investing by day to support his family and to help leave the world better than he found it. He’s the CEO & Managing Director of Rock Health, a venture fund focused on early stage digital health startups. Under his leadership, Rock Health launched a rapidly-growing, standalone advisory services business. Separate from the fund, Rock Health’s advisory services practice delivers strategic consulting services to enterprise-scale, publicly-traded companies. Prior to Rock Health, Bill was at Roche Diagnostics where he was a Senior Director responsible for launching Roche’s newly formed oncology decision support business unit, Navify. Previously he held various leadership roles at Genentech, a biotechnology company. Bill earned a Bachelor of Arts degree in Economics from Harvard University and began his career at Goldman Sachs before entering the startup world in the late 1990s as a software engineer in Silicon Valley.